10am – noon Pacific 11am – 1pm Mountain 12-2pm Central 1-3pm Eastern 2-4pm Atlantic 2:30-4:30pm Newfoundland & Labrador Public health in Canada responded dramatically to the COVID-19 crisis and not the overdose crisis. Join us for the Impact of the Pandemic on People Who Use Drugs: Part 1 as we connect.
At the request of the Government of Canada, the Canadian Research Initiative in Substance Misuse (CRISM) developed 6 national guidance documents that address the urgent needs of people who use substances, as well as service providers and decision makers during the COVID-19 pandemic. Health Canada and CRISM will be hosting a webinar, led by Dr. Julie Bruneau, to provide […]
The Harm Reduction Symposium will bring together many stakeholders to raise awareness, educate, and enhance harm reduction collaboration. CALL TO ACTION: As a community, it is our responsibility to improve the lives of those impacted by problematic substance use. To achieve this, we need to reduce stigma, increase community collaboration, and influence systematic changes. […]
Injectable opioid agonist treatment (iOAT) is a safe, life-saving, and cost-effective treatment option for individuals with severe opioid dependence. It is also virtually unavailable in Ontario. The need for iOAT has never been greater given an opioid crisis that has become the most enduring public health emergency in recent Canadian history and further fueled by […]
The three day event, presented by the Atlantic Policy Congress of First Nations Chiefs Secretariat, will feature speakers from across Canada discussing the theme Walking Together Through a Health Crisis and also include the Honouring Our People Awards. While this free event is open to the public, please note that the content will be tailored […]
Detailed program Presentation of the Guide d’usage optimal – Méthadone et buprénorphine de l’INESSS Presentation of the work conducted by the Équipe de soutien clinique et organisationnel en dépendance et itinérance on the use of once-daily slow-release morphine (MLLU) in OAT in Quebec. Interdisciplinary Panel on Safer Supply and Use of the MLLU Canadian Expert […]
Public health in Canada responded dramatically to the COVID-19 crisis and not the overdose crisis. Join us for the Impact of the Pandemic on People Who Use Drugs: Part 2 as we connect.
L’Institut universitaire sur les dépendances du Centre intégré universitaire de santé et de services sociaux du Centre-Sud-de-l’Île-de-Montréal organise présentement la 6e édition du colloque international TDO (traitement de la dépendance aux opioïdes). Le colloque TDO6 a une grande portée dans toute la francophonie ; en Europe, en Afrique et ici au Canada. Pour cette édition, le thème est Dialogues entre science et savoirs expérientiels : L’implication des usagers et […]
The Commission on Narcotic Drugs (CND) is the body mandated to develop drug policy at the global level and is the governing body of UNODC. The Commission will take place next week, from 12 to 16 April 2021 and, because of the pandemic, all commission proceedings will be available to watch on a live webcast. (Central European Time) […]
La majorité des personnes utilisatrices de drogues par injection (PUDI) contracteront le virus de l’hépatite C (VHC), les mettant à risque accru de complications hépatiques graves et parfois mortelles. Les comportements les plus risqués pour l’acquisition du VHC incluent le partage de matériel d’injection et l’injection à haute fréquence. Un facteur jusqu’ici négligé dans l’évaluation […]
